title: Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient.
authors.affiliation: Neurology Unit, Department of Neurosciences, University of Modena and Reggio Emilia, Nuovo Ospedale Civile Sant'Agostino Estense, Via Pietro Giardini, 1355, 41126, Modena, Italy, perdiana@tin.it.
authors.forename: D
authors.initials: D
authors.lastname: Ferraro
authors.forename: S
authors.initials: S
authors.lastname: De Biasi
authors.forename: F
authors.initials: F
authors.lastname: Vitetta
authors.forename: A M
authors.initials: AM
authors.lastname: Simone
authors.forename: L
authors.initials: L
authors.lastname: Federzoni
authors.forename: V
authors.initials: V
authors.lastname: Borghi
authors.forename: A
authors.initials: A
authors.lastname: Cossarizza
authors.forename: P F
authors.initials: PF
authors.lastname: Nichelli
authors.forename: P
authors.initials: P
authors.lastname: Sola
mesh_terms: D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects*; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000187:drug effects*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine